Evidence map›Paper›PMID 25885859›Full record

ArticleBMC infectious diseases2015

Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration.

Yao Abo, Marcel Zannou Djimon, Eugène Messou, Eric Balestre, Martial Kouakou, Jocelyn Akakpo, Carin Ahouada, Nathalie de Rekeneire, François Dabis, Charlotte Lewden and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Yao AboProgramme PAC-CI, Centre Hospitalier Universitaire (CHU) de Treichville, 18 BP 1954, Abidjan 18, Côte d'Ivoire. aysonabo@gmail.com.
Marcel Zannou DjimonCentre de Traitement Ambulatoire (CTA), Centre National Hospitalier Universitaire (CNHU), Cotonou, Benin. djmzannou@yahoo.fr.
Eugène MessouUniversity Bordeaux, ISPED, Bordeaux, France. messou_eugene@yahoo.fr.
Eric BalestreINSERM, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France. Eric.Balestre@isped.u-bordeaux2.fr.
Martial KouakouCentre de Prise en charge de Recherche et de Formation (Aconda-CePReF), Abidjan, Côte d'Ivoire. martchelo_ci@yahoo.fr.
Jocelyn AkakpoCentre de Traitement Ambulatoire (CTA), Centre National Hospitalier Universitaire (CNHU), Cotonou, Benin. jocen12@yahoo.fr.
Carin AhouadaCentre de Traitement Ambulatoire (CTA), Centre National Hospitalier Universitaire (CNHU), Cotonou, Benin. ahouada@yahoo.fr.
Nathalie de RekeneireINSERM, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France. Nathalie.De-Rekeneire@isped.u-bordeaux2.fr.
François DabisINSERM, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France. Francois.Dabis@isped.u-bordeaux2.fr.
Charlotte LewdenINSERM, Centre INSERM U897-Epidémiologie-Biostatistique, Bordeaux, France. Charlotte.lewden@riseup.net.
Albert MingaProgramme PAC-CI, Centre Hospitalier Universitaire (CHU) de Treichville, 18 BP 1954, Abidjan 18, Côte d'Ivoire. minga.albert@yahoo.fr.
IeDEA West Africa Collaboration
Bordeaux Population Health · FRCentre National Hospitalier et Universitaire Hubert Koutoukou MAGA · BJInserm · FRSociété de Développement des Forêts · CIUniversity Hospital Medical Center at Treichville · CI

Funding

WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
NIAID NIH HHS U01 AI069919NIAID NIH HHS U01AI069919
6 · The paper itself

Abstract

backgroundThe causes of severe morbidity in health facilities implementing Antiretroviral Treatment (ART) programmes are poorly documented in sub-Saharan Africa. We aimed to describe severe morbidity among HIV-infected patients after ART initiation, based on data from an active surveillance system established within a network of specialized care facilities in West African cities.

methodsWithin the International epidemiological Database to Evaluate AIDS (IeDEA)--West Africa collaboration, we conducted a prospective, multicenter data collection that involved two facilities in Abidjan, Côte d'Ivoire and one in Cotonou, Benin. Among HIV-infected adults receiving ART, events were recorded using a standardized form. A simple case-definition of severe morbidity (death, hospitalization, fever>38°5C, Karnofsky index<70%) was used at any patient contact point. Then a physician confirmed and classified the event as WHO stage 3 or 4 according to the WHO clinical classification or as degree 3 or 4 of the ANRS scale.

resultsFrom December 2009 to December 2011, 978 adults (71% women, median age 39 years) presented with 1449 severe events. The main diagnoses were: non-AIDS-defining infections (33%), AIDS-defining illnesses (33%), suspected adverse drug reactions (7%), other illnesses (4%) and syndromic diagnoses (16%). The most common specific diagnoses were: malaria (25%), pneumonia (13%) and tuberculosis (8%). The diagnoses were reported as syndromic in one out of five events recorded during this study.

conclusionsThis study highlights the ongoing importance of conventional infectious diseases among severe morbid events occurring in patients on ART in ambulatory HIV care facilities in West Africa. Meanwhile, additional studies are needed due to the undiagnosed aspect of severe morbidity in substantial proportion.

Indexed as

AdultAIDS-Related Opportunistic InfectionsAmbulatory Care FacilitiesAnti-HIV AgentsBeninCooperative BehaviorCote d'IvoireDatabases, FactualData CollectionFemaleFeverHIV InfectionsHospitalizationHumansKarnofsky Performance StatusMalariaAnti-HIV Agents

Identifiers

PMID25885859
PMCPMC4396560
OpenAlexW2159751053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.